CMS
67
5
GS
72
-8
MAT
45
-2
THC
79
2
VRSK
75
-2
AMP
78
2
TGT
57
-2
WM
77
-5
WRK
79
3
GIS
57
-3
CRM
59
4
SYK
60
7
ADBE
49
4
CMA
56
4
GPC
43
-2
PWR
75
4
SJM
36
-2
WDC
57
3
URBN
63
-3
MCHP
62
2
CMS
67
5
GS
72
-8
MAT
45
-2
THC
79
2
VRSK
75
-2
AMP
78
2
TGT
57
-2
WM
77
-5
WRK
79
3
GIS
57
-3
CRM
59
4
SYK
60
7
ADBE
49
4
CMA
56
4
GPC
43
-2
PWR
75
4
SJM
36
-2
WDC
57
3
URBN
63
-3
MCHP
62
2
Financhill
Back

Catheter Precision 10K Form

Sell
48

VTAK
Catheter Precision

Last Price:
0.61
Seasonality Move:
-43.7%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive VTAK News And Ratings

See the #1 stock for the next 7 days that we like better than VTAK

VTAK Financial Statistics

Sales & Book Value

Annual Sales: $442K
Cash Flow: $-1.96M
Price / Cash Flow: 0
Annual Sales: $2.45
Price / Book: 0.24

Profitability

EPS (TTM): 0.28000
Net Income (TTM): $-6.85M
Gross Margin: $412K
Return on Equity: -28.24%
Return on Assets: -19.49%

Catheter Precision Earnings Forecast

Key Catheter Precision Financial Ratios

  • The Gross Profit Margin over the past 8 years for VTAK is 93.21%.
  • The Selling, General & Administrative Expenses for VTAK have been equal to 3,873.76% of Gross Profit Margin.
  • The Research & Development expenses have been 107.47% of Revenue.
  • The Interest Expense is -7.95% of Operating Income.
  • The Net Earning history of VTAK is -15,966.52% of Total Revenues.
  • Per Share Earnings over the last 8 years have been positive in 4 years.

Catheter Precision Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NYAM
Industry: Health Care Equipment & Supplies
Sector: Health Care
Current Symbol: VTAK
Website: catheterprecision.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0.83
Quick Ratio: 0.67

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

VTAK Technical Analysis vs Fundamental Analysis

Sell
48
Catheter Precision (VTAK) is a Sell

Is Catheter Precision a Buy or a Sell?